Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Silvia Pasquini

Showing results (1-10 of 43) with videos related to

Pageof 5
Sort By:
International Journal of Molecular Sciences|November 21, 2020
Targeting Adenosine Receptors: A Potential Pharmacological Avenue for Acute and Chronic PainFabrizio Vincenzi, Silvia Pasquini, Pier Andrea Borea, et al.
International Journal of Molecular Sciences|July 24, 2021
Adenosine and Inflammation: Here, There and EverywhereSilvia Pasquini, Chiara Contri, Pier Andrea Borea, et al.
Frontiers in Pharmacology|October 24, 2022
Update on the recent development of allosteric modulators for adenosine receptors and their therapeutic applicationsSilvia Pasquini, Chiara Contri, Martina Cappello, et al.
Frontiers in Oncology|October 18, 2021
A<sub>3</sub> Adenosine and P2X7 Purinergic Receptors as New Targets for an Innovative Pharmacological Therapy of Malignant Pleural MesotheliomaFabrizio Vincenzi, John Charles Rotondo, Silvia Pasquini, et al.
Bioorganic & Medicinal Chemistry|June 9, 2018
Identification of novel thiazolo[5,4-d]pyrimidine derivatives as human A<sub>1</sub> and A<sub>2A</sub> adenosine receptor antagonists/inverse agonistsFlavia Varano, Daniela Catarzi, Matteo Falsini, et al.
Pharmaceuticals (Basel, Switzerland)|July 30, 2020
Piperazine- and Piperidine-Containing Thiazolo[5,4-<i>d</i>]pyrimidine Derivatives as New Potent and Selective Adenosine A<sub>2A</sub> Receptor Inverse AgonistsFlavia Varano, Daniela Catarzi, Erica Vigiani, et al.
International Journal of Molecular Sciences|February 15, 2022
Adenosine Receptors in Neuropsychiatric Disorders: Fine Regulators of Neurotransmission and Potential Therapeutic TargetsSilvia Pasquini, Chiara Contri, Stefania Merighi, et al.
International Journal of Molecular Sciences|January 20, 2021
Pulsed Electromagnetic Field Stimulation in Osteogenesis and Chondrogenesis: Signaling Pathways and Therapeutic ImplicationsKatia Varani, Fabrizio Vincenzi, Silvia Pasquini, et al.
International Journal of Molecular Sciences|October 31, 2020
Pulsed Electromagnetic Fields Stimulate HIF-1α-Independent VEGF Release in 1321N1 Human Astrocytes Protecting Neuron-Like SH-SY5Y Cells from Oxygen-Glucose DeprivationFabrizio Vincenzi, Silvia Pasquini, Stefania Setti, et al.
Cells|May 24, 2020
The Detrimental Action of Adenosine on Glutamate-Induced Cytotoxicity in PC12 Cells Can Be Shifted towards a Neuroprotective Role through A<sub>1</sub>AR Positive Allosteric ModulationFabrizio Vincenzi, Silvia Pasquini, Stefania Gessi, et al.
Pageof 5

Showing results (1-10 of 43) with videos related to

Sort By:
Pageof 5
International Journal of Molecular Sciences|November 21, 2020
Targeting Adenosine Receptors: A Potential Pharmacological Avenue for Acute and Chronic PainFabrizio Vincenzi, Silvia Pasquini, Pier Andrea Borea, et al.
International Journal of Molecular Sciences|July 24, 2021
Adenosine and Inflammation: Here, There and EverywhereSilvia Pasquini, Chiara Contri, Pier Andrea Borea, et al.
Frontiers in Pharmacology|October 24, 2022
Update on the recent development of allosteric modulators for adenosine receptors and their therapeutic applicationsSilvia Pasquini, Chiara Contri, Martina Cappello, et al.
Frontiers in Oncology|October 18, 2021
A<sub>3</sub> Adenosine and P2X7 Purinergic Receptors as New Targets for an Innovative Pharmacological Therapy of Malignant Pleural MesotheliomaFabrizio Vincenzi, John Charles Rotondo, Silvia Pasquini, et al.
Bioorganic & Medicinal Chemistry|June 9, 2018
Identification of novel thiazolo[5,4-d]pyrimidine derivatives as human A<sub>1</sub> and A<sub>2A</sub> adenosine receptor antagonists/inverse agonistsFlavia Varano, Daniela Catarzi, Matteo Falsini, et al.
Pharmaceuticals (Basel, Switzerland)|July 30, 2020
Piperazine- and Piperidine-Containing Thiazolo[5,4-<i>d</i>]pyrimidine Derivatives as New Potent and Selective Adenosine A<sub>2A</sub> Receptor Inverse AgonistsFlavia Varano, Daniela Catarzi, Erica Vigiani, et al.
International Journal of Molecular Sciences|February 15, 2022
Adenosine Receptors in Neuropsychiatric Disorders: Fine Regulators of Neurotransmission and Potential Therapeutic TargetsSilvia Pasquini, Chiara Contri, Stefania Merighi, et al.
International Journal of Molecular Sciences|January 20, 2021
Pulsed Electromagnetic Field Stimulation in Osteogenesis and Chondrogenesis: Signaling Pathways and Therapeutic ImplicationsKatia Varani, Fabrizio Vincenzi, Silvia Pasquini, et al.
International Journal of Molecular Sciences|October 31, 2020
Pulsed Electromagnetic Fields Stimulate HIF-1α-Independent VEGF Release in 1321N1 Human Astrocytes Protecting Neuron-Like SH-SY5Y Cells from Oxygen-Glucose DeprivationFabrizio Vincenzi, Silvia Pasquini, Stefania Setti, et al.
Cells|May 24, 2020
The Detrimental Action of Adenosine on Glutamate-Induced Cytotoxicity in PC12 Cells Can Be Shifted towards a Neuroprotective Role through A<sub>1</sub>AR Positive Allosteric ModulationFabrizio Vincenzi, Silvia Pasquini, Stefania Gessi, et al.
Pageof 5